<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-RI25HZ4D</identifier><date>2021</date><creator>Čeplak Mencin, Vid</creator><creator>Mesti, Tanja</creator><creator>Mileva Boshkoska, Biljana</creator><creator>Ocvirk, Janja</creator><relation>documents/doc/R/URN_NBN_SI_doc-RI25HZ4D_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-RI25HZ4D_001.txt</relation><format format_type="volume">55</format><format format_type="type">article</format><format format_type="issue">iss. 3</format><format format_type="extent">str. 354-361</format><identifier identifier_type="DOI">10.2478/raon-2021-0019</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID_HOST">62417667</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-RI25HZ4D</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">immune related adverse events</subject><subject language_type_id="eng">immunotherapy</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">melanom</subject><subject language_type_id="eng">melanoma</subject><subject language_type_id="eng">metastases</subject><subject language_type_id="slv">metastaze</subject><subject language_type_id="slv">neželeni učinki</subject><title>Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes</title></Record>